- Home
- RSF vs PLUR Comparison
RSF vs PLUR Comparison
Compare RSF & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSF
- PLUR
- Stock Information
- Founded
- RSF 2016
- PLUR 2001
- Country
- RSF United States
- PLUR Israel
- Employees
- RSF N/A
- PLUR N/A
- Industry
- RSF Investment Managers
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RSF Finance
- PLUR Health Care
- Exchange
- RSF Nasdaq
- PLUR Nasdaq
- Market Cap
- RSF 52.3M
- PLUR 41.9M
- IPO Year
- RSF N/A
- PLUR N/A
- Fundamental
- Price
- RSF $14.66
- PLUR $3.96
- Analyst Decision
- RSF
- PLUR Strong Buy
- Analyst Count
- RSF 0
- PLUR 1
- Target Price
- RSF N/A
- PLUR $12.00
- AVG Volume (30 Days)
- RSF 11.8K
- PLUR 17.1K
- Earning Date
- RSF 01-01-0001
- PLUR 05-13-2025
- Dividend Yield
- RSF 10.61%
- PLUR N/A
- EPS Growth
- RSF N/A
- PLUR N/A
- EPS
- RSF N/A
- PLUR N/A
- Revenue
- RSF N/A
- PLUR $1,034,000.00
- Revenue This Year
- RSF N/A
- PLUR $472.39
- Revenue Next Year
- RSF N/A
- PLUR $254.29
- P/E Ratio
- RSF N/A
- PLUR N/A
- Revenue Growth
- RSF N/A
- PLUR 203.23
- 52 Week Low
- RSF $14.81
- PLUR $3.33
- 52 Week High
- RSF $16.23
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- RSF 37.25
- PLUR 37.09
- Support Level
- RSF $14.63
- PLUR $4.04
- Resistance Level
- RSF $14.79
- PLUR $4.50
- Average True Range (ATR)
- RSF 0.08
- PLUR 0.40
- MACD
- RSF -0.00
- PLUR -0.05
- Stochastic Oscillator
- RSF 13.29
- PLUR 7.03
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.